Lifelong benefits following brief exposure to Rapamycin - LTF Literature Highlight Series
Longevitytech.fund Blog
by
1y ago
This week we wish to highlight the recently published Nature article from Juricic, P. et. al titled “Long-lasting geroprotection from brief rapamycin treatment in early adulthood by persistently increased intestinal autophagy ..read more
Visit website
Can CRISPR solve aging?
Longevitytech.fund Blog
by
1y ago
Silver Tsunami is here and real - people over 60 years of age are becoming an increasingly large percentage of the total population which is creating an imbalance in healthcare spending. Neurodegenerative disorders, cancer, metabolic and inflammatory diseases are some of the most prevalent age-related pathologies affecting this growing population. The most imperative and critical requirement to understand the pathological mechanisms of the diseases is understanding the functions of a gene or multiple genes in primary human cells and targeting them ..read more
Visit website
AI in Longevity - Where are we now and where are we going? - Webinar Summary
Longevitytech.fund Blog
by
1y ago
Artificial intelligence has been embedded into all walks of human lives, including health and medicine. But many of us don’t even know the true impacts AI has had on improving human health. As we move to launching our second $100 million fund we are actively thinking about the impacts AI will have on longevity. So come join our distinguished panel including Vladislav Severa (Partner LTF), Jan Antolik (Software Architect, HealthLongevity.data), Raghav Sehgal (Scientific Venture consultant), and Vit Haratek (Venture consultant) as they shed light on the transformative impact AI has on medicine a ..read more
Visit website

Follow Longevitytech.fund Blog on FeedSpot

Continue with Google
Continue with Apple
OR